The global acetaminophen API market is poised for significant growth, with recent projections indicating that it will exceed USD 1,180.4 million in 2023 and reach a valuation of USD 1,648.2 million by 2033. This promising outlook is supported by a robust Compound Annual Growth Rate (CAGR) of 3.4% from 2023 to 2033, as highlighted in the latest market analysis.
Acetaminophen, known for its widespread use as an over-the-counter and prescription medication for pain relief and fever reduction, continues to experience increasing global demand. Key factors driving this surge include the aging population, the expansion of healthcare systems, and growing healthcare expenditures in various countries.
Achieve Success In The Acetaminophen API Market With Our Data-Rich Sample Report: Pave The Way For Your Business Growth
The aging population worldwide is a critical factor contributing to the rising demand for acetaminophen. As the population ages, the prevalence of chronic pain and related conditions increases, leading to a higher need for effective pain management solutions. Acetaminophen, being a well-established and widely accepted option, is positioned to play a pivotal role in addressing these healthcare needs.
Moreover, the expansion of healthcare systems, particularly in emerging economies, is further fueling the demand for acetaminophen. As healthcare access improves and more people gain access to medical care, the use of essential medications like acetaminophen is expected to rise significantly. Additionally, increasing healthcare expenditures in various countries are supporting the growth of the acetaminophen API market.
The global acetaminophen API market is also benefiting from ongoing research and development efforts aimed at improving the efficacy and safety of acetaminophen-based products. These advancements are expected to enhance the therapeutic applications of acetaminophen, further boosting its market growth.
As the market continues to expand, key industry players are investing in innovative manufacturing processes and strategic collaborations to strengthen their market presence. These initiatives are expected to drive the growth of the acetaminophen API market and create new opportunities for market participants.
Key Takeaways from Acetaminophen API industry Report:
- In 2018, the global market size stood at USD 1,039.1 million.
- The market expanded at a CAGR of 2.1% from 2018 to 2022.
- In 2022, the global market size stood at USD 1,150.2 million.
- North America captured 33.4% of global market shares in 2022.
- China captured 4.6% of global market shares in 2022.
- Japan captured 5.2% of global market shares in 2022.
- The United Kingdom captured 3.8 global market shares in 2022.
- The pharmaceutical industry segment under end-user captured 38.60% of global market shares in 2022.
- The acetaminophen injection segment acquired 31.40% of global market shares in 2022.
Recent Developments Observed by FMI:
- Genexa unveiled the first-ever clean adult acetaminophen painkiller products in May 2022. The active components and dosages of Genexas Acetaminophen Extra Strength and Acetaminophen PM caplets are the same as those of the market leaders despite the absence of artificial colors, synthetic fillers, and other artificial preservatives.
- In April 2023, Haleon, a multinational consumer healthcare firm, launched its first analgesic from organic ingredients thanks to WhiteGrey’s marketing. PanaNatra is the first item in a new ‘naturals’ subcategory from the producers of Panadol, and it debuted with the marketing slogan ‘Who Said Natural Hasn’t Got What It Takes?
Equip Your Business with the Insights from Our Full Report for Optimal Growth
Key Players in the Global Market:
- BOC Sciences
- Tianjin Bofa Acetaminophen
- Mallinckrodt plc
- Kemcolour International
- Chnagshu Huagang Acetaminophen
- Haohua Industry
- Kangle Acetaminophen
- Angene International Limited
- Anhui BBCA Acetaminophen
- Granules India
- Hebei Jihgeng Acetaminophen
Acetaminophen API industry Segmentation:
By Type:
- Veterinary Drug Grade Acetaminophen API
- Acetaminophen Grade Acetaminophen API
By End User:
- Pharmaceutical Industry
- Research Labs
- Educational Institutes
- Others
By Product Form:
- Acetaminophen Tablets (Film-coated, Extended-release)
- Oral Acetaminophen
- Acetaminophen Suppository
- Acetaminophen Injection
- Others
By Indications:
- Antipyretic Acetaminophen APIs
- Acetaminophen Analgesics
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- The Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
